Evidence map›Paper›PMID 29854726›Full record

ReviewBioMed research international2018

Jéssica P Álvarez-Rendón, Rocío Salceda, Juan R Riesgo-Escovar

Abstract readReview
In one paragraph

Review in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Biology · 2026
    Review
  2. Review
  3. Article
  4. Chemical Profiling andNutrients · 2026
    Article
  5. Review
  6. Review
  7. Antidiabetes study ofJournal of Taibah University Medical Sciences · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Mistletoe infestedFood chemistry. Molecular sciences · 2022
    Article
  12. International journal of molecular sciences · 2022
    Review
  13. Article
  14. Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  15. Review
  16. Review
  17. Biomolecules · 2022
    Article
  18. Article
  19. Article
  20. Metabolic Syndrome: Lessons from Rodent andBioMed research international · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jéssica P Álvarez-RendónInstituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM Juriquilla, Boulevard Juriquilla No. 3001, 76226 Querétaro, QRO, Mexico.
Rocío SalcedaInstituto de Fisiología Celular, Universidad Nacional Autónoma de México, Avenida Universidad No. 3000, Colonia Universidad Nacional Autónoma de México, Delegación Coyoacán, 04510 Ciudad de México, Mexico.
Juan R Riesgo-EscovarInstituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM Juriquilla, Boulevard Juriquilla No. 3001, 76226 Querétaro, QRO, Mexico.ORCID 0000-0001-5493-6806

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDiabetes Mellitus, Type 2Disease ProgressionDrosophila melanogasterHumansInsulinSignal TransductionInsulin

Identifiers

PMID29854726
PMCPMC5941822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.